Got $10,000? Lockheed Martin Could Be a Defense Powerhouse That Outlasts Trump's Term

Lockheed Martin reported Q1 2026 revenue of $18.0B versus $18.3B expected and EPS of $6.44 versus $6.74 consensus, with shares falling nearly 5% on the day. Sales were flat year over year, operating margin fell 160 bps to 11.7%, and net margin slipped 110 bps to 8.3%, but management highlighted multiyear Pentagon agreements to scale munitions production, including Patriot, THAAD and PrSM. Full-year 2026 EPS guidance of $29.35-$30.25 implies up to 37% growth at the midpoint, though near-term cash flow is pressured by higher capex and ramp-up spending.

Analysis

The market is treating this as a clean earnings miss, but the more important signal is that LMT is deliberately converting itself from a margin-optimized platform vendor into a capacity-constrained munitions supplier. That is usually painful for 1-2 quarters because capex, working capital, and startup inefficiencies hit before volume does, but it can be accretive for several years if the backlog is tied to multiyear procurement and the industrial base remains tight. The setup is less about current-quarter EPS and more about whether management can lock in higher throughput without a permanent step-down in returns on capital.

The second-order winner is not necessarily LMT alone; it is the adjacent missile supply chain and test/equipment vendors that benefit from the same rearmament cycle without taking on the prime contractor’s margin compression or political scrutiny. If production truly triples on Patriot/THAAD/PrSM lines, the bottlenecks will likely migrate to guidance components, solid rocket motors, energetics, and specialty manufacturing capacity, creating upside for less visible suppliers before it shows up in prime margins. That makes this a “picks-and-shovels of defense” trade rather than a simple long-the-prime story.

The key risk is that the current de-rating may be partially justified if Washington keeps pushing cost discipline while insisting on faster delivery: volume can rise while returns stay stuck. If the Pentagon changes procurement cadence, delays funding, or reintroduces pressure on dividends/buybacks, LMT’s multiple could stay capped even as reported revenue improves. The contrarian point is that the selloff may be overdone if investors are anchoring on near-term margin dilution and missing the possibility that the next 12-24 months become an earnings acceleration phase once the factories and contracts roll through.

Key Decisions for Investors

• Buy LMT on weakness, but only as a 6-12 month hold: the setup offers a possible 15-25% upside if 2026 guidance proves achievable, with downside protected by backlog and multiyear contract visibility; size modestly because margin recovery is not immediate.
• Pair trade: long LMT / short a defense ETF basket or a higher-multiple industrial name over the next 1-3 months, betting that the market is over-penalizing the prime while ignoring the coming earnings inflection from missile volume.
• Prefer supplier exposure over the prime: add exposure to missile/propulsion and defense-electronics beneficiaries on any weakness, since their earnings should inflect before LMT’s and their margins are less exposed to political pricing pressure.
• Use a staged entry rather than buying all at once: initiate 1/3 now, add on any post-earnings drift lower, and reassess after the next procurement update; the catalyst window is months, not days.
• If holding LMT, hedge with an out-of-the-money call overwrite only after the next contract announcement, not now, because the upside skew is higher than usual if volume expansion is validated in coming quarters.